Seeking Alpha

  Vermillion, Inc. - NASDAQ

11/27/2014, 9:27 AM ET
  • Duediligence101 | Send Message 30 Mar 2011

    VRML Great science, huge open ended opportunity. CEO has made it a bad stock over the past year. OVA1 ramp and PAD approval are key.
    Reply (1)
    • sundate36 | Send Message 21 Dec 2012
      : Would you buy VRML at 1.40? 2013 seems to be looking good for them. Thanks!
      VRML vs. ETF Alternatives
      Company Description
      Vermillion Inc is engaged in discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients with gynecologic cancers and related diseases.